Seroprevalence of SARS‐CoV‐2 infection in the general population of Nepal during the first and second generalized waves of the COVID‐19 pandemic—2020–2021
Influenza and Other Respiratory Viruses · 2023
DOI: 10.1111/irv.13234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2023. Verfasst von Krishna Prasad Paudel und 41 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Disease Control Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Few seroprevalence studies have been conducted on coronavirus disease (COVID‐19) in Nepal. Here, we aimed to estimate seroprevalence and assess risk factors for infection in the general population of Nepal by conducting two rounds of sampling. The first round was in October 2020, at the peak of the first generalized wave of COVID‐19, and the second round in July–August 2021, following the peak of the wave caused by the delta variant of SARS‐CoV‐2. We used cross‐sectional probability‐to‐size (PPS)‐based multistage cluster sampling to estimate the seroprevalence in the general population of Nepal at the national and provincial levels. We tested for anti‐SARS‐CoV‐2 total antibody using the WANTAI SARS‐CoV‐2 Ab ELISA kit. In Round 1, the overall national seroprevalence was 14.4%, with provincial estimates ranging from 5.3% in Sudurpaschim to 27.3% in Madhesh Province. In Round 2, the estimated national seroprevalence was 70.7%, with the highest in the Madhesh Province (84.8%) and the lowest in the Gandaki Province (62.9%). Seroprevalence was comparable between males and females (Round 1, 15.8% vs. 12.2% and Round 2, 72.3% vs. 68.7%). The seroprevalence in the ecozones—Terai, hills, and mountains—was 76.3%, 65.3%, and 60.5% in Round 2 and 17.7%, 11.7%, and 4.6% in Round 1, respectively. In Nepal, COVID‐19 vaccination was introduced in January 2021. At the peak of the first generalized wave of COVID‐19, most of the population of Nepal remained unexposed to SARS‐CoV‐2. Towards the end of the second generalized wave in April 2021, two thirds of the population was exposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology and Disease Control Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal.
- WHO Country Office for Nepal, Kathmandu, Nepal.
- National Public Health Laboratory, Ministry of Health and Population, Kathmandu, Nepal.
- DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki, Japan.
- Central Bureau of Statistics, National Planning Commission, Kathmandu, Nepal.
- National Health Research Council, Kathmandu, Nepal.
ORCID-Profile: Basu Dev Pandey, Shaikh Shah Hossain, Govindakarnavar Arunkumar, Anindya Sekhar Bose, Shashi Kandel
Förderung
- World Health Organization
Zitieren
APA
Paudel, K. P., Samuel, R., Jha, R., Pandey, B. D., Edirisuriya, C., Shrestha, N. L., Gyawali, P., Pokhrel, A., Shrestha, L., Mahato, R. K., Hossain, S. S., Arunkumar, G., Bose, A. S., Dhimal, M., Gautam, D., Neupane, S., Thakur, N., Shrestha, S., Bhusal, N., …, & Pokhrel, R. (2023). Seroprevalence of SARS‐CoV‐2 infection in the general population of Nepal during the first and second generalized waves of the COVID‐19 pandemic—2020–2021. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13234
Vancouver
Paudel KP, Samuel R, Jha R, Pandey BD, Edirisuriya C, Shrestha NL, et al. Seroprevalence of SARS‐CoV‐2 infection in the general population of Nepal during the first and second generalized waves of the COVID‐19 pandemic—2020–2021. Influenza and Other Respiratory Viruses. 2023. doi:10.1111/irv.13234
BibTeX
@article{Paudel2023,
author = {Paudel, Krishna Prasad and Samuel, Reuben and Jha, Runa and Pandey, Basu Dev and Edirisuriya, Chathura and Shrestha, Nebin Lal and Gyawali, Pradip and Pokhrel, Amrit and Shrestha, Lilee and Mahato, Ram Kumar and Hossain, Shaikh Shah and Arunkumar, Govindakarnavar and Bose, Anindya Sekhar and Dhimal, Meghnath and Gautam, Dipendra and Neupane, Subash and Thakur, Nishant and Shrestha, Saugat and Bhusal, Nirajan and Jha, Priya and Gupta, Binod Prasad and Rayamajhi, Rajan Bikram and Subedi, Koshal Chandra and Kandel, Shashi and Poudel, Mukesh and Thapa, Lila Bikram and Sharma, Guna Nidhi and Gocotano, Allison Eugenio and Sunny, Avinash K and Gautam, Rabin and Bhatta, Deepak Raj and Awale, Bal Krishna and Roka, Bhola and Ojha, Hemant Chandra and Baral, Phanindra and Adhikari, Mahendra Dhose and Lohani, Guna Raj and Shrestha, Mahendra and Singh, Dipendra Raman and Aryal, Laxman and Pandav, Rajesh Sambhajirao and Pokhrel, Roshan},
title = {Seroprevalence of SARS‐CoV‐2 infection in the general population of Nepal during the first and second generalized waves of the COVID‐19 pandemic—2020–2021},
journal = {Influenza and Other Respiratory Viruses},
year = {2023},
doi = {10.1111/irv.13234}
}
EUVIMED